First Manhattan CO Scopus Bio Pharma Inc. Transaction History

First Manhattan CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $0.45 $2,921 - $5,715	-12,700 Reduced 49.22%	13,100 $3,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $4.28 $3,260 - $8,560	-2,000 Reduced 7.19%	25,800 $42,000
Q3 2021 Nov 15, 2021	BUY	$4.0 - $6.99 $74,000 - $129,315	18,500 Added 198.92%	27,800 $115,000
Q2 2021 Aug 16, 2021	SELL	$5.17 - $10.25 $5,170 - $10,250	-1,000 Reduced 9.71%	9,300 $66,000
Q1 2021 May 14, 2021	SELL	$7.94 - $14.87 $794 - $1,487	-100 Reduced 0.96%	10,300 $87,000
Q4 2020 Feb 16, 2021	BUY	$5.92 - $33.96 $61,568 - $353,184	10,400 New	10,400 $154,000

100

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.